162 related articles for article (PubMed ID: 7439991)
1. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.
Humphres RC; Henika PR; Ferraresi RW; Krahenbuhl JL
Infect Immun; 1980 Nov; 30(2):462-6. PubMed ID: 7439991
[TBL] [Abstract][Full Text] [Related]
2. Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice.
Krahenbuhl JL; Sharma SD; Ferraresi RW; Remington JS
Infect Immun; 1981 Feb; 31(2):716-22. PubMed ID: 7216470
[TBL] [Abstract][Full Text] [Related]
3. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
4. Failure of synthetic muramyl dipeptide to increase antibacterial resistance.
Finger H; Wirsing von König CH
Infect Immun; 1980 Feb; 27(2):288-91. PubMed ID: 6155329
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
Fraser-Smith EB; Matthews TR
Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666
[TBL] [Abstract][Full Text] [Related]
6. Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
Osada Y; Mitsuyama M; Une T; Matsumoto K; Otani T; Satoh M; Ogawa H; Nomoto K
Infect Immun; 1982 Jul; 37(1):292-300. PubMed ID: 6809630
[TBL] [Abstract][Full Text] [Related]
7. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
Leclerc C; Juy D; Bourgeois E; Chedid L
Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
[No Abstract] [Full Text] [Related]
8. Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice.
Masihi KN; Brehmer W; Lange W; Ribi E; Schwartzman S
J Biol Response Mod; 1984 Dec; 3(6):663-71. PubMed ID: 6439830
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of nonspecific host resistance to infection induced by muramyldipeptides.
Matsumoto K; Ogawa H; Nagase O; Kusama T; Azuma I
Microbiol Immunol; 1981; 25(10):1047-58. PubMed ID: 7031443
[TBL] [Abstract][Full Text] [Related]
10. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
[TBL] [Abstract][Full Text] [Related]
11. Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptides.
Bahr GM; Chedid LA; Behbehani K
Cell Immunol; 1987 Jul; 107(2):443-54. PubMed ID: 3496165
[TBL] [Abstract][Full Text] [Related]
12. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
Chedid LA; Parant MA; Audibert FM; Riveau GJ; Parant FJ; Lederer E; Choay JP; Lefrancier PL
Infect Immun; 1982 Feb; 35(2):417-24. PubMed ID: 7035362
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1.
Iribe H; Koga T
Cell Immunol; 1984 Oct; 88(1):9-15. PubMed ID: 6332683
[TBL] [Abstract][Full Text] [Related]
14. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
[TBL] [Abstract][Full Text] [Related]
15. Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro.
Bakker-Woudenberg IA; Lokerse AF; Vink-van den Berg JC; Roerdink FH
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):603-9. PubMed ID: 2506020
[TBL] [Abstract][Full Text] [Related]
16. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L; Carelli C; Audibert F
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
[No Abstract] [Full Text] [Related]
17. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
[TBL] [Abstract][Full Text] [Related]
18. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
Löwy I; Leclerc C; Chedid L
Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092
[TBL] [Abstract][Full Text] [Related]
19. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
Sone S; Tsubura E
J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine.
Matsumoto K; Otani T; Une T; Osada Y; Ogawa H; Azuma I
Infect Immun; 1983 Mar; 39(3):1029-40. PubMed ID: 6341226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
